Connect with us

Stocks

Investment Opportunities in Techno Drugs Considering Financial Viability

Published

on

Techno Drugs

Techno Drugs Limited’s private company primarily focuses on specialized products, offering a range of products in Oncology, Anesthesia, Birth Control Pills, Injections, and modern technology Implant sticks (for 5-year birth control). The company was registered as a private company in 2009 and converted into a public company in 2019. Additionally providing veterinary and general human medicines.

 

Their main medicines include:

Birth Control Medicines: Sukhi 3rd Generation oral pill, Provera Injection, Implant Stick 5 years birth control
Anti-cancer Medicines: Hertin, Zolomide, Eposide
Anesthesia Medicines: Lidocaine plus Inj, Vencuron-10 IV Inj
General Human Medicines: Motilex Suspension, Omsec, Romilac, Cefixon Injection.
Veterinary Medicines: Vermic Inj, Dexavet Inj, Rumen plus pow, Vitazinc Sol

Techno Drugs Limited has been advancing in producing and distributing high-quality medicines. The company’s management director, Mehereen Ahmed, holds a PhD in Oncology from Dhaka University, ensuring expertise in the field. The management team and staff work diligently to ensure quality.

Every year, Techno Drugs Limited supplies the highest amount of birth control medicines in opposition to tenders from the Family Planning Directorate of the Bangladesh Government. With 17 depots across the country, they ensure nationwide distribution. The company also has a “24/7 Monitoring Team” at every level to ensure proper monitoring of all company operations.

With listing on the stock market, Techno Drugs Limited anticipates increased production and sales, benefiting investors and stockholders. Their commitment to corporate governance, job creation, business expansion through IPO funds, and regular dividends to investors aims at socio-economic development in the country and enhancing the country’s reputation in the global pharmaceutical market.

Techno Drugs continues to produce life-saving medicines and is progressing as a profitable company. With various specialized products and a wide range of human and veterinary medicines, they aim for further advancement in the future. Currently, the company’s total capital is approximately 94 crores taka with management holding 63% and the management board having 88% of the shares. Techno Drugs believes that with their capable management and dedicated staff, they will achieve more success in the future, making it a secure investment for investors.

Share this

Stocks

Indices at Ease after 9 Working-Days Volatility

Published

on

Bourse dse turnover indices stock market

Dhaka Stock Exchange DSE, Bourse on the second working day of the week, 26th May, ended with a hike in Indices and Turnover from the previous working session. This information is known from DSE sources.

506 crore 12 lakh taka shares were traded on this day. 183 crore 75 lakh more tradings were done in DSE today compared to the previous workday, 23th May , Shares worth Tk 322 crores 75 lakh shares were traded last time, Tuesday

The benchmark DSEX added 59.66 points or 5,310 The Shariah-based index DSES gained 13.70 points or 1,160, and the blue-chip index DS30 decreased by 11.93 points or 1,900.

Of the issues traded, 276 advanced, 84 declined and 34 remained unchanged.

Index Agro Industries Limited ranked top gainer on DSE, the share price increased by Tk 5.80 paisa or 9.73 percent. On this day, the share was last traded at Tk 65.40 paisa.

Unilever Consumer Care Limited ranked top loser on the DSE, the share price dropped by Tk 64.100 paisa or 3 percent. On this day, the share was last traded at Tk 2,076.00 paisa.

DSE topped on trade is Unilever Consumer Care Limited 33 crore 56 lakh takas of company shares have been traded.

A total of 36 companies’ shares were traded in the Block on Dhaka Stock Exchange. A total of 1 crore 26 lakh 28 thousand 218 shares of the companies were traded. The financial value of which is 49 crore 54 lakh taka

Share this
Continue Reading

Stocks

Khan Brothers releases Q2 Financials

Published

on

One of the listed companies, Khan Brothers PP Woven Bag Industries Limited discloses its financial reports for the second quarter, (October– December 23).

The company’s earnings per share (EPS) loss Tk 0.01 paisa in Q2 of the current financial year (October – December 23). EPS was loss Tk 0.01 paisa during the same period last year. NAV per share was Tk. 11.84 as of December 31, 2023.

Share this
Continue Reading

Stocks

Standard Ceramics’ EPS on Massive Losses in Third Quarter

Published

on

Standard Ceramic

One of the listed companies, Standard Ceramic Industries Limited discloses its financial reports for the third quarter, (January – March 24).

The company’s earnings per share (EPS) was loss Tk 3.26 paisa in Q3 of the current financial year (January – March 24). EPS was loss Tk 2.03 paisa during the same period last year. As of March 31, 2024, at the end of the third quarter of the fiscal year, the company’s net asset value (NAV) per share stood at loss Tk 30.13.

Share this
Continue Reading